FAIRplus Innovation and SME Forum: Implementing FAIR data principles in ind...
Date and time
Location
Kendrew Lecture Theatre
Wellcome Genome Campus
Hinxton
Cambridgeshire
CB10 1SA
United Kingdom
Description
FAIRplus Innovation and SME Forum
Implementing FAIR data principles in industrial life science research
Date: 29 January 2020
Time: 09:00-17:00
WHO SHOULD ATTEND?
- Biotech companies working with data
- Technology companies planning to provide FAIRification services
- Academic groups interested in FAIRification of their data collections
THE AGENDA INCLUDES:
- Introduction to FAIRplus
- Guidelines for making data FAIR
- SME Flashtalks
- Hands-on session on FAIRification
- Flash Talks
The full programme is available here
For more details on FAIRplus please visit the FAIRplus website.
Location
The location of this event is:
The Kendrew Lecture Theatre
Wellcome Genome Campus
Hinxton, Cambridgeshire
CB10 1SD, UK
More details on how to find us including travelling by car or train can be found on our website.
Accommodation
On campus Conference Centre - A limited number of bedrooms are being held at the Conference Centre on campus. These are issued on first-come-first serve basis. The cost is £102 with payment due on check out. To book your room, please contact: 01223 495000 quoting REFERENCE NO: 17427
Please note, the Conference Centre can only guarantee these rooms till 1 December.
Off campus Holiday Inn - A limited number of bedrooms are being held at the Holiday Inn, Whittelsford. There is a limited capacity bus to campus, alternatively, you will need to arrange a taxi to get to campus. Rooms are issued on first-come-first serve basis. Payment is due on check out. To book, please contact: 01223 497070 quoting REFERENCE NO: ELI
Registration deadline: Friday 10 January 2020
REMINDER: We are hosting our first FAIRplus Annual Review on Thursday 30 and Friday 31 January. It is free to attend and takes place at the same location but registation must be completed separately. Please click here to register.
FAIRplus has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 802750. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA Companies. This communication reflects the views of the authors and neither IMI nor the European Union, EFPIA or any Associated Partners are liable for any use that may be made of the information contained herein.
-
Carole Goble
ELIXIR Professor of Computer Science at the University of Manchester -
Philip Gribbon
Frauenhofer -
Susanna Sansone
University of Oxford Associate Director, Associate Professor - FAIR Data Science -
Serena Scollen
ELIXIR Head of Human Genomics and Translational Data -
Herman van Vlijmen
Janssen Pharmaceutical Companies of Johnson & Johnson Senior Director, Computational Chemistry